| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-06 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.18 | 0.0005 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0009 |